Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer is a research paper published in Frontiers in Molecular Biosciences (2021). On theSindex it has a DataRank of 0. It has been cited 57 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL093339
NIGMS NIH HHS
Grant: R24 GM137782
NCI NIH HHS
Grant: U01 CA225784
NIA NIH HHS
Grant: R56 AG062344
NIGMS NIH HHS
Grant: P41 GM103390
National Institutes of Health
Grant: 5R01HL093339-02
Heparan sulfate proteoglycan interacts with Slit/Robo to regulate angiogenesis
National Institutes of Health
Grant: 1U01CA225784-01
Heparan Sulfate in Prostate Cancer
National Institutes of Health
Grant: 1R56AG062344-01
Heparan sulfate proteoglycan in Alzheimer's disease
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
FWCI
3.15
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals